The Immunomodulatory Effects of Anti-thyroid Drugs are Mediated via Actions on Thyroid Cells, Affecting Thyrocyte-immunocyte Signalling A Review
Keywords: Anti-thyroid Drugs; Graves disease; Grubeck Loebenstein; Immunomodulatory Effects; Soluble interleukin; Thyrocyte immunocyte Signalling; Thyroid Antibodies; immunosuppressive; interferon gamma production; lectin stimulated thyrocyte; thyroperoxidase
Document Type: Review Article
Publication date: April 1, 2001
- Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.
Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- Ingenta Connect is not responsible for the content or availability of external websites